The maintenance of personnel records was inadequate.
Inspection Record
Unilever Canada Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The design of the drug stability study was inadequate and/or not justified with a documented rationale.
The temperature and/or humidity control was inadequate.
The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
The quality agreement outlining the responsibilities for fabricating, packaging or labelling, and/or testing was inadequate.
The assessment to release finished products was inadequate.
The implementation of a self-inspection program was inadequate.
The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.
The written procedures for recalls were inadequate.
The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The annual product quality review procedure was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2024-03-21. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
